Australia’s treasurer is flagging budget cuts as global turmoil bites, and that puts dependable income front and center for local investors. When cash rates move and policy shifts, the comfort of steady, well covered dividends can feel scarce. This is where higher yielding Australian dividend stocks paying more than 3% come in. This article highlights three options from that universe that combine yield with a focus on stability and dividends.
The three stocks below are just a sample from this higher yield universe, while the full screen on Simply Wall St surfaced 36 more companies with similarly income focused stories that are not covered here. To size up that broader opportunity set, head straight to the Dividend Powerhouses (3%+ Yield) screener to identify, filter and analyze the highest conviction dividend plays.
Objective (ASX:OCL)
Objective Corporation is a pure-play software group built around information governance, compliance and secure document handling. This fits neatly with a screener focused on dependable dividends supported by recurring, contract-driven income from government and regulated clients.
Objective generates about A$135 million of revenue from software and programming, serving public sector and regulated customers, and has a market value of roughly A$575 million, which puts it firmly in mid cap territory for Australian investors.
"When Objective's software is embedded in a government department, handling classified records, managing regulatory compliance, or processing building applications, replacing it means operational chaos. The cost of switching isn't just money; it's years of disruption no bureaucracy will volunteer for."
What ultimately matters for dividend investors is how this sticky position holds up if one important pressure point on the business model shifts.
If you want to see how that pressure point could reset Objective’s income story, read the full narrative for Objective and see what the raw numbers might be masking.
Vita Life Sciences (ASX:VLS)
Vita Life Sciences sells branded vitamins and supplements under Herbs of Gold, VitaHealth and VitaScience, aligning naturally with a cash-generating dividend story. It produces about A$43 million from Australia and A$46 million from Malaysia and Singapore, with smaller contributions from China and Vietnam, and has a market value near A$149 million.
Vita Life Sciences combines a 5.07% yield with earnings that grew 19.8% year over year and a P/E of 13.4x against far richer sector averages. That mix of income, growth and valuation appeal all comes back to how one unseen pressure on its payout discipline plays out.
If that unseen pressure on payout discipline has you curious, run Vita Life Sciences through the analysis report for Vita Life Sciences before that income story quietly shifts gears
Fiducian Group (ASX:FID)
Fiducian Group leans on funds management and platform administration to turn client portfolios into recurring fee income, which directly supports its Dividend Powerhouses profile as a higher yielding, income focused stock.
Fiducian Group earns A$37 million from Funds Management, A$34 million from Financial Planning and A$24 million from Platform Administration, with smaller Corporate Services income. This gives it an Australia centered A$271 million mid cap profile.
For dividend investors, Fiducian Group matters because its core funds management and wrap platform engine is built around recurring fees that can underpin regular cash payouts, even when sentiment toward the stock is shaped by regulatory headlines.
"Bad press involving misleading statements and compliance failures even more so. On 3 October 2025, Fiducian Group Ltd (ASX:FID) announced that ASIC had commenced civil proceedings against one of its subsidiaries, Fiducian Investment Management Services Ltd (FIMS)."
Income holders now need to watch how one unresolved pressure on Fiducian’s business model filters through to payout comfort and future growth.
That pressure is the real story, and the full narrative for Fiducian Group shows how Fiducian Group’s income engine could be decoupling from the headline noise.
Seeking Alternatives Before Others Catch On
Fresh ideas move first. By the time every investor is talking about a breakout, early momentum has already flown. Scan under the radar for now, do the work while it matters, then get in early.
- Target reliable balance sheets and resilient cash generators before they get widely followed by running the list of solid balance sheet and fundamentals (12 results) today.
- Hunt for resilient growers using the 7 resilient stocks with low risk scores and focus on businesses where measured risk scores meet steady fundamentals before the crowd catches up.
- Identify early strength in the gold space by scanning the 36 elite gold producer stocks and focus on producers that appear to be building momentum before sentiment starts to shift more broadly.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com